Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Type II collagen-specific antibodies induce cartilage damage in mice independent of inflammation.

Croxford AM, Whittingham S, McNaughton D, Nandakumar KS, Holmdahl R, Rowley MJ.

Arthritis Rheum. 2013 Mar;65(3):650-9. doi: 10.1002/art.37805.

2.

Chemical changes demonstrated in cartilage by synchrotron infrared microspectroscopy in an antibody-induced murine model of rheumatoid arthritis.

Croxford AM, Nandakumar KS, Holmdahl R, Tobin MJ, McNaughton D, Rowley MJ.

J Biomed Opt. 2011 Jun;16(6):066004. doi: 10.1117/1.3585680.

PMID:
21721805
3.

Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro.

Crombie DE, Turer M, Zuasti BB, Wood B, McNaughton D, Nandakumar KS, Holmdahl R, Van Damme MP, Rowley MJ.

Arthritis Res Ther. 2005;7(5):R927-37. Epub 2005 Jun 6.

4.

Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.

Nandakumar KS, Bajtner E, Hill L, Böhm B, Rowley MJ, Burkhardt H, Holmdahl R.

Arthritis Rheum. 2008 Jan;58(1):184-96. doi: 10.1002/art.23049.

6.

Pathogenic antibody recognition of cartilage.

Nandakumar KS.

Cell Tissue Res. 2010 Jan;339(1):213-20. doi: 10.1007/s00441-009-0816-8. Epub 2009 Jun 9. Review.

PMID:
19506910
7.

Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.

Hutamekalin P, Saito T, Yamaki K, Mizutani N, Brand DD, Waritani T, Terato K, Yoshino S.

J Immunol Methods. 2009 Mar 31;343(1):49-55. doi: 10.1016/j.jim.2009.01.009.

PMID:
19330909
8.

Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.

Burkhardt H, Koller T, Engström A, Nandakumar KS, Turnay J, Kraetsch HG, Kalden JR, Holmdahl R.

Arthritis Rheum. 2002 Sep;46(9):2339-48.

9.

Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen.

Bajtner E, Nandakumar KS, Engström A, Holmdahl R.

Arthritis Res Ther. 2005;7(5):R1148-57. Epub 2005 Jul 27.

10.

Effect of NOS2 gene deficiency on the development of autoantibody mediated arthritis and subsequent articular cartilage degeneration.

Kato H, Nishida K, Yoshida A, Takada I, McCown C, Matsuo M, Murakami T, Inoue H.

J Rheumatol. 2003 Feb;30(2):247-55.

PMID:
12563676
11.

Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells.

Amirahmadi SF, Whittingham S, Crombie DE, Nandakumar KS, Holmdahl R, Mackay IR, van Damme MP, Rowley MJ.

Arthritis Rheum. 2005 Jun;52(6):1897-906.

12.

An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes.

Amirahmadi SF, Pho MH, Gray RE, Crombie DE, Whittingham SF, Zuasti BB, Van Damme MP, Rowley MJ.

Immunol Cell Biol. 2004 Aug;82(4):427-34.

PMID:
15283854
13.

Specific antibody protection of the extracellular cartilage matrix against collagen antibody-induced damage.

Croxford AM, Crombie D, McNaughton D, Holmdahl R, Nandakumar KS, Rowley MJ.

Arthritis Rheum. 2010 Nov;62(11):3374-84. doi: 10.1002/art.27671.

14.
15.

Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.

Lubberts E, Joosten LA, van Den Bersselaar L, Helsen MM, Bakker AC, van Meurs JB, Graham FL, Richards CD, van Den Berg WB.

J Immunol. 1999 Oct 15;163(8):4546-56.

16.

Pathogenic autoreactive B cells are not negatively selected toward matrix protein collagen II.

Cao D, Khmaladze Ia, Jia H, Bajtner E, Nandakumar KS, Blom T, Mo JA, Holmdahl R.

J Immunol. 2011 Nov 1;187(9):4451-8. doi: 10.4049/jimmunol.1101378. Epub 2011 Sep 21. Erratum in: J Immunol. 2012 Sep 15;189(6):3263.

17.
18.

IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies.

Johansson AC, Hansson AS, Nandakumar KS, Bäcklund J, Holmdahl R.

J Immunol. 2001 Sep 15;167(6):3505-12. Erratum in: J Immunol 2002 Nov 15;169(10):6056.

20.

TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.

Mukherjee P, Wu B, Mayton L, Kim SH, Robbins PD, Wooley PH.

Ann Rheum Dis. 2003 Aug;62(8):707-14.

Supplemental Content

Support Center